Ceat | Ceat share price: Price hikes to continue, Ceat pushing for growth to accelerate in second half: Arnab Banerjee

Ceat | Ceat share price: Price hikes to continue, Ceat pushing for growth to accelerate in second half: Arnab Banerjee

Arnab Banerjee, MD & CEO, Ceat, says price hikes will continue because the pass-through to the tyres per se is inadequate if cumulative price hikes from April to August are taken. Ceat has been able to pass on maybe 4%, in barely a couple of categories, but in a large number of categories, they have … Read more

Hospital stocks’ growth outlook positive: HSBC

Hospital stocks’ growth outlook positive: HSBC

HSBC initiated coverage on Krishna Institute of Medical Sciences (KIMS) with a ‘buy’ rating while assigning ‘reduce’ rating to Global Health (Medanta) and Narayana Hrudayalaya. The brokerage has a ‘buy’ rating on Apollo Hospitals and Aster Healthcare. “We retain our positive view on the growth outlook for the hospital sector on intact structural drivers: An … Read more

Sharekhan By BNP Paribas: 2 top stock picks from Foram Parekh for near term

Sharekhan By BNP Paribas: 2 top stock picks from Foram Parekh for near term

“In North America, Revlimid is the key contributor and again, speciality drugs for Zydus Lifesciences that will keep on increasing EBITDA margins towards 29-30% and also in the valuation-wise Zydus Life is not trading at much higher valuations like Sun, therefore we feel that Zydus Life is also a second stock which can see good … Read more

honasa shares: Honasa shares surge 7% after reporting Rs 30 crore profit in Q4. Should you buy, sell or hold?

honasa shares: Honasa shares surge 7% after reporting Rs 30 crore profit in Q4. Should you buy, sell or hold?

Shares of Honasa Consumer, which owns Mamearth, rallied 7% in Friday’s session on BSE to the day’s high of Rs 447.70 after reporting a net profit of Rs 30.4 crore for the quarter ended March 2024 against a loss of Rs 161.7 crore in the last year quarter. Honasa clocked its highest-ever profit during the … Read more

Anupam Rasayan: There’s a slowdown in agro segment but better traction in pharma, monomers & personal care: Anupam Rasayan management

Anupam Rasayan: There’s a slowdown in agro segment but better traction in pharma, monomers & personal care: Anupam Rasayan management

Vishal Thakkar, Deputy CFO and Gopal Agrawal, CEO, Anupam Rasayan, in conversation with ET Now. Agrawal says: “Even in FY24, our EBITDA margins have been steady and that is precisely the reason where the nature of the contract with our customers has helped. While, one could see a little bit of a pressure overall, for … Read more

TVS Motor: TVS Motor’s product mix, caution on EV discounts help retain edge

TVS Motor: TVS Motor’s product mix, caution on EV discounts help retain edge

The TVS Motor stock is trading at 35 times its one-year forward earnings, compared with the long-term average of 28 times. Synopsis A better product mix and a judicious call on staying away from EV scooter discounting should fatten margins. The maker of Apache expanded its margins by 114 basis points on a year-on-year basis … Read more

New Year-2024 stock picks: 8 largecap ideas that can rally up to 25% – Money Making Ideas

New Year-2024 stock picks: 8 largecap ideas that can rally up to 25% – Money Making Ideas

Sun Pharmaceutical Industries. Share Price 1294.30 01:39 PM | 02 Jan 2024 33.71(2.67%) Divi’s Laboratories. Share Price 4017.05 01:39 PM | 02 Jan 2024 101.16(2.58%) Coal India. Share Price 391.85 01:39 PM | 02 Jan 2024 9.65(2.52%) Cipla. Share Price 1277.25 01:39 PM | 02 Jan 2024 26.25(2.09%) Oil And Natural Gas Corporation. Share Price … Read more